Literature DB >> 30094586

The IMPDH inhibitors, ribavirin and mycophenolic acid, inhibit peste des petits ruminants virus infection.

Qiu-Yan Chang1,2, Fu-Cheng Guo1, Xue-Rui Li3, Jian-Hua Zhou4, Xuepeng Cai3, Qiuwei Pan1,2, Xiao-Xia Ma5,6,7.   

Abstract

Peste des petits ruminants virus (PPRV) causes highly contagious diseases in domestic and particular wild small ruminants, leading to substantial economic loss. The development of effective and cheap antiviral medications shall help to circumvent this emerging burden. In this study, we found that ribavirin, a competitive inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor, significantly inhibits the replication of PPRV. As IMPDH is a key enzyme in purine nucleotide synthesis, supplementation of exogenous guanosine attenuate the anti-PPRV effect of ribavirin. Interestingly, an uncompetitive IMPDH inhibitor, mycophenolic acid (MPA), exerted more potent antiviral effect again PPRV. Similarly, this effect was largely restored upon supplementation of guanosine. Thus, we have demonstrated that the IMPDH inhibitors ribavirin and MPA combat PPRV infection through purine nucleotide depletion. Because both regimens have been widely used in the clinic for treating viral infection or organ rejection in transplantation patients for decades, respectively, repurposing these existing safe and cheap medications may provide a new avenue for combating PPRV infection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30094586     DOI: 10.1007/s11259-018-9733-1

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  32 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Vaccination for the control of peste des petits ruminants.

Authors:  A Diallo
Journal:  Dev Biol (Basel)       Date:  2004

Review 3.  Vaccines against peste des petits ruminants virus.

Authors:  Arnab Sen; Paramasivam Saravanan; Vinayagamurthy Balamurugan; Kaushal Kishor Rajak; Shashi Bhushan Sudhakar; Veerakyathappa Bhanuprakash; Satya Parida; Raj Kumar Singh
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

Review 4.  The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus.

Authors:  N M Dixit; A S Perelson
Journal:  Cell Mol Life Sci       Date:  2006-04       Impact factor: 9.261

5.  Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.

Authors:  J Casey; K Morris; M Narayana; M Nakagaki; G A Kennedy
Journal:  Bone Marrow Transplant       Date:  2013-08-05       Impact factor: 5.483

6.  Self-assembly and release of peste des petits ruminants virus-like particles in an insect cell-baculovirus system and their immunogenicity in mice and goats.

Authors:  Wenchao Li; Hongyan Jin; Xiukun Sui; Zhanzhong Zhao; Chenghuai Yang; Wenquan Wang; Junping Li; Gang Li
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

Review 7.  Sofosbuvir: a novel oral agent for chronic hepatitis C.

Authors:  Evangelos Cholongitas; George V Papatheodoridis
Journal:  Ann Gastroenterol       Date:  2014

8.  Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.

Authors:  Changbo Qu; Lei Xu; Yuebang Yin; Maikel P Peppelenbosch; Qiuwei Pan; Wenshi Wang
Journal:  Arch Virol       Date:  2017-06-16       Impact factor: 2.574

9.  Evolutionary dynamics of recent peste des petits ruminants virus epidemic in China during 2013-2014.

Authors:  Jingyue Bao; Qinghua Wang; Lin Li; Chunju Liu; Zhicheng Zhang; Jinming Li; Shujuan Wang; Xiaodong Wu; Zhiliang Wang
Journal:  Virology       Date:  2017-07-19       Impact factor: 3.616

Review 10.  Mechanisms of action of ribavirin against distinct viruses.

Authors:  Jason D Graci; Craig E Cameron
Journal:  Rev Med Virol       Date:  2006 Jan-Feb       Impact factor: 6.989

View more
  1 in total

Review 1.  Discovery and applications of nucleoside antibiotics beyond polyoxin.

Authors:  Hiroyuki Osada
Journal:  J Antibiot (Tokyo)       Date:  2019-09-25       Impact factor: 2.649

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.